Browsing by Author "Djordjević, Valentina (7005657086)"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Early-onset ischaemic stroke in a patient with the novel F2 c.1824C>T gene variant and PAI-1 4G/4G, MTHFR 677TT genotype; [Ishemijski moždani udar u mlađem životnom dobu kod bolesnika sa novom F2 c.1824C>T genskom varijantom i PAI-1 4G/4G, MTHFR 677TT genotipom](2022) ;Pruner, Iva (36350119000) ;Dinčić, Evica (6602112999) ;Gvozdenov, Maja (55937902600) ;Tomić, Branko (14421786200) ;Kovač, Mirjana (7102654168)Djordjević, Valentina (7005657086)Introduction. Ischemic stroke (IS) is a heterogeneous disorder caused by several genetic and environmental risk factors. It was suggested that coagulation disorders cause 1-4% of cases with IS, especially in patients with early onset of IS. Case report. We describe a case of a young adult male who developed an unprovoked IS. Biochemical, immunological, and thrombophilia screening, as well as DNA sequencing, were performed in order to reveal molecular pathology underlying the stroke of the patient. Thrombophilia testing showed that patient was a homozygous carrier for PAI-1 4G/5G and MTHFR C677T mutations. Additional genetic analysis revealed the presence of the recently reported F2 c.1824C>T gene variant, located in the last exon of the prothrombin gene and has previously been shown to cause hyperprothrombinemia, hypofibrinolysis, and altered fibrin clot phenotype. Conclusion. Our results suggest that the newly reported F2 c.1824C>T gene variant might have a synergistic effect with PAI 4G/4G and MTHFR 677TT genotype in the formation of altered fibrin clot phenotype characterized by thin, densely packed fibrin fibers, which makes clot less susceptible to fibrinolysis and greatly increases the risk for early ischemic stroke onset. © The Author(s) 2022. - Some of the metrics are blocked by yourconsent settings
Publication Predictive genetic markers of coagulation, inflammation and apoptosis in Perthes disease—Serbian experience(2015) ;Srzentić, Sanja (57204289670) ;Nikčević, Gordana (6602344117) ;Spasovski, Duško (25028865800) ;Baščarević, Zoran (6506868841) ;Živković, Zorica (57224757364) ;Terzic-Šupić, Zorica (15840732000) ;Matanović, Dragana (21739989500) ;Djordjević, Valentina (7005657086) ;Pavlović, Sonja (7006514877)Spasovski, Vesna (26655022200)Perthes disease is one of the most common forms of pediatric femoral head osteonecrosis with an unknown etiology. Coagulation factors were the first genetic factors suspected to have a role in the pathogenesis of this disease, but studies showed inconsistent results. It is described that inflammation is present during early stages of Perthes disease, but its genetic aspect has not been studied extensively. Little is known regarding the status of apoptotic factors during the repair process that leads to the occurrence of hip deformity in patients. Therefore, the aim of this study was to analyze major mediators involved in coagulation, inflammation, and apoptotic processes as possible causative factors of Perthes disease. The study cohort consisted of 37 patients. Gene variants of TNF-α, FV, FII, and MTHFR genes were determined by PCR-RFLP, while IL-3 and PAI-1 were genotyped by direct sequencing. The expression level of Bax, Bcl-2, Bcl2L12, Fas and FasL was analyzed by quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) technique. Our results showed a significantly increased level of expression of pro-apoptotic factor Bax along with significantly higher Bax/Bcl-2 ratio in the patient group. Conclusion: The results presented indicate that apoptosis could be one of the factors contributing to the lack of balanced bone remodeling process in Perthes patients. © 2015, Springer-Verlag Berlin Heidelberg.
